| Ms Margaret Mary Mcmahon, APN, CNS | |
|
100 Aura Rd Apt 208, Clayton, NJ 08312-1406 | |
| (856) 881-4692 | |
| Not Available |
| Full Name | Ms Margaret Mary Mcmahon |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 100 Aura Rd Apt 208, Clayton, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336481076 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR08638500 (New Jersey) | Secondary |
| 163W00000X | Registered Nurse | 26NJ00262600 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Margaret Mary Mcmahon, APN, CNS 100 Aura Rd Apt 208, Clayton, NJ 08312-1406 Ph: (856) 881-4692 | Ms Margaret Mary Mcmahon, APN, CNS 100 Aura Rd Apt 208, Clayton, NJ 08312-1406 Ph: (856) 881-4692 |
News Archive
Velomedix, Inc., a venture-backed medical device company advancing the field of therapeutic hypothermia, announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to expand the design of its VELOCITY pilot clinical trial.
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today the completion of the purchase of Surgical Biologics, a leader in the development of tissue processing techniques for creating implants for a variety of surgical indications from amnion membranes.
A recent study, published in the American Society for Microbiology's journal, mSphere, evaluated the use of many liquid chalk products as antiseptics against the transmission of highly pathogenic human viruses such as influenza A virus (H1N1), SARS-CoV-2, (IAV), and norovirus in a mouse norovirus (MNV) model. The researchers applied chalk before or after virus inoculum and determined the recovery of infectious virus to mimic its use in the gym setting.
A Ludwig Cancer Research study adds to growing evidence that immune cells known as macrophages inhabiting the body cavities that house our vital organs can aid tumor growth by distracting the immune system's cancer-killing CD8+ T cells.
› Verified 9 days ago
Renee Smallhorne, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4 Tanglewood Cir, Clayton, NJ 08312 Phone: 856-725-8165 |